Clinical Pharmacology and Pharmacokinetics of Pirmenol

Reiter, Michael J.
March 1988
Angiology;Mar1988 Part 2, Vol. 39, p293
Academic Journal
Pirmenol hydrochloride is a promising antiarrythmic agent with quinidine-like (Class Ia) properties presently undergoing evaluation. It's clinical pharmacology and pharmacokinetics are reviewed. The author outlines the effects of pirmenol on the sinus node, atrial tissue, A-V node, and ventricular tissue and describes its antiarrhythmic efficacy in clinical studies to date, including his own study in 21 patients with a history of sustained ventricular tachycardia. The author summarizes the hemodynamic and pharmacokinetic studies of pirmenol noting that its effects are relatively independent of postassium concentration. The drug's side effects profile is presented, and it is concluded that pirmenol is well tolerated. Hypotension has not been a significant problem with intravenous pirmenol. Precipitation or worsening of clinical heart failure appears to occur only rarely. The favorable pharmacokinetics of pirmenol permit dosage at less frequent intervals than with procainamide, quinidine, disopyamide. Pirmenol has shown efficacy for ventricular arrhythmias even in some patients refractory to Class Ia agents. Antiarrhythmic effects appear to be correlated with plasma levels, and a well-defined therapeutic minimum has been determined.


Related Articles

  • Short- and Long-Acting Oral Quinidine Preparations. Woo, Elaine; Greenblatt, David J. // Angiology;Mar1978, Vol. 29 Issue 3, p243 

    Discusses the clinical implications of pharmacokinetic differences of short- and long-acting oral quinidine preparations. Absorption properties of oral quinidine gluconate; Use of quinidine to suppress ventricular arrhythmias; Maintenance dose and dosing interval.

  • THE EFFECT OF QUINIDINE ON EXPERIMENTAL COMPETITIVE CARDIAC PACING. Rothfeld, Edwin L.; Zucker, I. Richard; Lotti, Luigi; Parsonnet, Victor; Bernstein, Arthur // Angiology;Feb1967, Vol. 18 Issue 2, p122 

    No ventricular arrhythmias occurred during competitive pacing between the sinus node and an artificial pacemaker in 20 normal dogs. After intravenous quinidine serious ventricular arrhythmias triggered by pacemaker stimuli falling in the vulnerable period of sinus beats were noted in 14 of the...

  • Tachycardia-Aggravated Heart Disease. Engel, Toby R.; Bush, Charles A.; Schaal, Stephen F. // Annals of Internal Medicine;Mar74, Vol. 80 Issue 3, p384 

    Describes a case in which a patient developed ventricular dysfunction after the onset of chronic sinoatrial tachycardia. Details of the clinical characteristic of the patient; Results of the electrocardiogram and cardiac catheterization administered on the patient; Entities in which chronic...

  • Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs. Mehvar, R.; Brocks, D.R.; Vakily, M.; Mehvar, Reza; Brocks, Dion R; Vakily, Majid // Clinical Pharmacokinetics;2002, Vol. 41 Issue 8, p533 

    Many antiarrhythmic drugs introduced into the market during the past three decades have a chiral centre in their structure and are marketed as racemates. Most of these agents, including disopyramide, encainide, flecainide, mexiletine, propafenone and tocainide, belong to class I antiarrhythmics,...

  • Management of Ventricular Arrhythmias in the Elderly. Huffman, Grace Brooke // American Family Physician;01/15/2000, Vol. 61 Issue 2, p535 

    Focuses on a study by W.S. Aronow which recommended against treatment with antiarrhythmic medications in older asymptomatic patients with nonsustained ventricular tachycardia (VT) but without cardiac disease. Principles of treatment for VT; Basis for the diagnosis of VT; Prevalence of...

  • QT Interval Prolongation and Atypical Proarrhythmia: Monomorphic Ventricular Tachycardia with Trimebutine. Schiariti, Michele; Saladini, Angela; Placanica, Attilio; Saolini, Marta; Puddu, Paolo E. // Open Pharmacology Journal;2009, Vol. 3, p32 

    A 59-year old woman was admitted at emergency for palpitation and dizziness. Medication history showed trimebutine 450 mg daily, because of meteorism, increased to 450 mg TID a week earlier. At admittance, sustained monomorphic ventricular tachycardia was interrupted by 100 mg intravenous...

  • Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. Doki, Kosuke; Homma, Masato; Kuga, Keisuke; Aonuma, Kazutaka; Sakai, Satoshi; Yamaguchi, Iwao; Kohda, Yukinao // European Journal of Clinical Pharmacology;Oct2007, Vol. 63 Issue 10, p951 

    We examined the effect of gender-associated differences in pharmacokinetics on the anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia and in healthy subjects. The study population comprised 72 outpatients (52 males and 20 females) treated with oral...

  • Sinus Arrest during Radiofrequency Ablation of the Atrioventricular-Node Slow Pathway. Mathuria, Nilesh; Bobek, Jaromir; Afshar, Hamid // Texas Heart Institute Journal;2009, Vol. 36 Issue 5, p477 

    Radiofrequency ablation has been associated with changes in autonomic function. In this case, a 52-year-old woman was referred for electrophysiologic study of recurrent supraventricular tachycardia. Typical slow/fast atrioventricular node re-entry tachycardia was induced and confirmed during the...

  • supraventricular tachycardia. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p722 

    An encyclopedia entry for "supraventricular tachycardia" is presented. It refers to an abnormally fast but regular heart rate that happens in episodes that vary in duration from several hours to several days. The condition is triggered when abnormal electrical impulses that arise in the atria of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics